← Leaderboards
Martin G Pomper
Johns Hopkins University
$38,517,075
Attributed
$46,608,817
Total exposure
38
Grants
28
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$68,177,042 · 40
By mechanism
R01$17,509,952 · 7
U54$15,618,677 · 5
P41$13,579,436 · 7
R24$5,054,722 · 1
R21$4,130,874 · 8
R33$3,313,885 · 3
Top collaborators
- Andrew G Horti10 shared
- Michael Rod Zalutsky10 shared
- Richard F. Ambinder5 shared
- Peter C Searson5 shared
- George Sgouros5 shared
- Joseph M Backer3 shared
- Theodore L Deweese3 shared
- Wojciech Lesniak2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Barbara Stauch Slusher$18,499,514
- Kannan Rangaramanujam$10,355,612
- Shawn Lupold$4,097,268
- Sangeeta Ray$1,939,833
- Takashi Tsukamoto$11,312,957
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImagePositron-Emission TomographyBaseMalignant NeoplasmsIn VivoTumorProgramsMolecular ImagingImaging AgentRadiotracerMalignant Neoplasm Of ProstateDrug KineticsAffinityClinicBiologicalAnimalsTissuesCellsFundingDesignPre-ClinicalRadiation TherapyResourcesSmall Molecule
Grant awards (151)
Resource for Molecular Imaging Agents in Precision Medicine$1,354,694
P41 · FY2025 · EB · contact PI
Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer$675,688
R01 · FY2025 · CA · contact PI
Enhanced imaging and treatment of aggressive subtypes of prostate cancer$428,295
R01 · FY2025 · CA · contact PI
Administration-Resource for Molecular Imaging Agents in Precision Medicine$349,175
P41 · FY2025 · EB · contact PI
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer$298,937
U54 · FY2025 · CA · contact PI
Targeted nanotechnology for the pancreatic tumor immune microenvironment$201,715
P41 · FY2025 · EB · contact PI
Resource for Molecular Imaging Agents in Precision Medicine$1,436,774
P41 · FY2024 · EB · contact PI
Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer$692,072
R01 · FY2024 · CA · contact PI
Enhanced imaging and treatment of aggressive subtypes of prostate cancer$428,718
R01 · FY2024 · CA · contact PI
Administration-Resource for Molecular Imaging Agents in Precision Medicine$374,448
P41 · FY2024 · EB · contact PI
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer$282,739
U54 · FY2024 · CA · contact PI
ZnT8-specific bioanalytical tools for probing autoimmune destruction of pancreatic beta-cells in type-1 diabetes$235,403
R56 · FY2024 · DK
Targeted nanotechnology for the pancreatic tumor immune microenvironment$208,538
P41 · FY2024 · EB · contact PI
Enhanced imaging and treatment of aggressive subtypes of prostate cancer$456,081
R01 · FY2023 · CA · contact PI
Small Molecule PSMA-Targeted Alpha Therapy$423,933
R01 · FY2023 · CA · contact PI
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer$289,427
U54 · FY2023 · CA · contact PI
Small Molecule PSMA-Targeted Alpha Therapy$1
R01 · FY2023 · CA · contact PI
Enhanced imaging and treatment of aggressive subtypes of prostate cancer$443,607
R01 · FY2022 · CA · contact PI
Small Molecule PSMA-Targeted Alpha Therapy$362,164
R01 · FY2022 · CA · contact PI
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer$350,268
U54 · FY2022 · CA · contact PI
Training for Clinician Scientists in Imaging Research$192,251
T32 · FY2022 · EB · contact PI
Resource for Molecular Imaging Agents in Precision Medicine$1,179,527
P41 · FY2021 · EB · contact PI
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation$604,751
R01 · FY2021 · AG
Small Molecule PSMA-Targeted Alpha Therapy$389,581
R01 · FY2021 · CA · contact PI
Imaging Agents for Inflammatory Components of Malignancy$257,860
P41 · FY2021 · EB · contact PI
Training for Clinician Scientists in Imaging Research$180,559
T32 · FY2021 · EB · contact PI
Training/Dissemination - Resource for Molecular Imaging Agents in Precision Medicine$93,306
P41 · FY2021 · EB · contact PI
Administration - Resource for Molecular Imaging Agents in Precision Medicine$77,939
P41 · FY2021 · EB · contact PI
Enhanced imaging and treatment of aggressive subtypes of prostate cancer$27,784
R01 · FY2021 · CA · contact PI
Resource for Molecular Imaging Agents in Precision Medicine$1,203,600
P41 · FY2020 · EB · contact PI
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation$617,907
R01 · FY2020 · AG
PET imaging of soluble epoxide hydrolase (sEH) in human subjects$530,176
R33 · FY2020 · AG
Enhanced imaging and treatment of aggressive subtypes of prostate cancer$473,165
R01 · FY2020 · CA · contact PI
Small Molecule PSMA-Targeted Alpha Therapy$319,250
R01 · FY2020 · CA · contact PI
Imaging Agents for Inflammatory Components of Malignancy$261,872
P41 · FY2020 · EB · contact PI
PEG-Prom Mediated Theranostics for Prostate Cancer$212,222
P50 · FY2020 · CA · contact PI
Training for Clinician Scientists in Imaging Research$195,450
T32 · FY2020 · EB · contact PI
Training/Dissemination - Resource for Molecular Imaging Agents in Precision Medicine$97,317
P41 · FY2020 · EB · contact PI
Administration - Resource for Molecular Imaging Agents in Precision Medicine$81,952
P41 · FY2020 · EB · contact PI
Resource for Molecular Imaging Agents in Precision Medicine$1,203,878
P41 · FY2019 · EB · contact PI
PET imaging of soluble epoxide hydrolase (sEH) in human subjects$531,439
R33 · FY2019 · AG
High-Specificity Imaging Agents for Aggressive Prostate Cancer$381,302
R01 · FY2019 · CA · contact PI
Resource for Molecular Imaging Agents in Precision Medicine$310,425
P41 · FY2019 · EB · contact PI
Imaging Agents for Inflammatory Components of Malignancy$262,151
P41 · FY2019 · EB · contact PI
Training for Clinician Scientists in Imaging Research$255,663
T32 · FY2019 · EB · contact PI
Training/Dissemination - Resource for Molecular Imaging Agents in Precision Medicine$97,318
P41 · FY2019 · EB · contact PI
Administration - Resource for Molecular Imaging Agents in Precision Medicine$81,950
P41 · FY2019 · EB · contact PI
Resource for Molecular Imaging Agents in Precision Medicine$1,368,554
P41 · FY2018 · EB · contact PI
Small Molecule PSMA-Targeted Alpha Therapy$401,678
R01 · FY2018 · CA · contact PI
High-Specificity Imaging Agents for Aggressive Prostate Cancer$396,577
R01 · FY2018 · CA · contact PI
Training for Clinician Scientists in Imaging Research$322,932
T32 · FY2018 · EB · contact PI
PET imaging of soluble epoxide hydrolase (sEH) in human subjects$283,367
R21 · FY2018 · AG
Imaging Agents for Inflammatory Components of Malignancy$260,132
P41 · FY2018 · EB · contact PI
Administration - Resource for Molecular Imaging Agents in Precision Medicine$248,161
P41 · FY2018 · EB · contact PI
PEG-Prom Mediated Theranostics for Prostate Cancer$224,298
P50 · FY2018 · CA · contact PI
Training/Dissemination - Resource for Molecular Imaging Agents in Precision Medicine$97,317
P41 · FY2018 · EB · contact PI
Resource for Molecular Imaging Agents in Precision Medicine$1,563,638
P41 · FY2017 · EB · contact PI
High-Specificity Imaging Agents for Aggressive Prostate Cancer$468,164
R01 · FY2017 · CA · contact PI
Small Molecule PSMA-Targeted Alpha Therapy$418,621
R01 · FY2017 · CA · contact PI
Administration - Resource for Molecular Imaging Agents in Precision Medicine$414,530
P41 · FY2017 · EB · contact PI
PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics$393,306
U01 · FY2017 · CA · contact PI
PET imaging of soluble epoxide hydrolase (sEH) in human subjects$285,822
R21 · FY2017 · AG
Theranostics of Reduction of Cardiotoxicity Using Targeted Apoptosis Activation Technology$274,452
R43 · FY2017 · CA
Imaging Agents for Inflammatory Components of Malignancy$259,734
P41 · FY2017 · EB · contact PI
PEG-Prom Mediated Theranostics for Prostate Cancer$235,449
P50 · FY2017 · CA · contact PI
Training/Dissemination - Resource for Molecular Imaging Agents in Precision Medicine$96,614
P41 · FY2017 · EB · contact PI
High-Specificity Imaging Agents for Aggressive Prostate Cancer$526,681
R01 · FY2016 · CA · contact PI
Clinical development of 18F PET tracer for imaging VEGF receptors$456,892
R44 · FY2016 · CA
Small Molecule PSMA-Targeted Alpha Therapy$404,015
R01 · FY2016 · CA · contact PI
PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics$394,519
U01 · FY2016 · CA · contact PI
PEG-Prom Mediated Theranostics for Prostate Cancer$219,786
P50 · FY2016 · CA · contact PI
Clinical development of 18F PET tracer for imaging VEGF receptors$1,016,118
R44 · FY2015 · CA
High-Specificity Imaging Agents for Aggressive Prostate Cancer$573,775
R01 · FY2015 · CA · contact PI
PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics$410,209
U01 · FY2015 · CA · contact PI
Small Molecule PSMA-Targeted Alpha Therapy$388,423
R01 · FY2015 · CA · contact PI
PEG-Prom Mediated Theranostics for Prostate Cancer$218,727
P50 · FY2015 · CA · contact PI
Theranostic Imaging of Metastatic Prostate Cancer$191,803
P50 · FY2015 · CA · contact PI
Center of Cancer Nanotechnology Excellence at Johns Hopkins$2,326,373
U54 · FY2014 · CA
BETR Therapy for Herpesvirus-Associated Tumors$520,698
R01 · FY2014 · CA · contact PI
Small Molecule PSMA-Targeted Alpha Therapy$465,015
R01 · FY2014 · CA · contact PI
Extrathalamic nAChR-PET for Imaging Neurodegeneration$408,809
R33 · FY2014 · AG
PEG-Prom Mediated Theranostics for Prostate Cancer$241,971
P50 · FY2014 · CA · contact PI
Developmental Activities$234,659
U54 · FY2014 · CA · contact PI
Clinical development of 18F PET tracer for imaging VEGF receptors$222,920
R44 · FY2014 · CA
Theranostic Imaging of Metastatic Prostate Cancer$186,681
P50 · FY2014 · CA · contact PI
Validation$127,937
U54 · FY2014 · CA · contact PI
Center of Cancer Nanotechnology Excellence at Johns Hopkins$1,758,130
U54 · FY2013 · CA
Developmental Activities$522,157
U54 · FY2013 · CA · contact PI
TK-based Infection Imaging$432,369
R01 · FY2013 · EB · contact PI
Extrathalamic nAChR-PET for Imaging Neurodegeneration$374,007
R33 · FY2013 · AG
PSMA-based Cancer Imaging Agents$310,286
R01 · FY2013 · CA · contact PI
Validation$236,530
U54 · FY2013 · CA · contact PI
Theranostic Imaging of Metastatic Prostate Cancer$195,284
P50 · FY2013 · CA · contact PI
BETR Therapy for Herpesvirus-Associated Tumors$1
R01 · FY2013 · CA · contact PI
Center of Cancer Nanotechnology Excellence at Johns Hopkins$2,527,954
U54 · FY2012 · CA
BETR Therapy for Herpesvirus-Associated Tumors$550,261
R01 · FY2012 · CA · contact PI
TK-based Infection Imaging$515,932
R01 · FY2012 · EB · contact PI
Extrathalamic nAChR-PET for Imaging Neurodegeneration$442,400
R33 · FY2012 · AG
Developmental Activities$341,957
U54 · FY2012 · CA · contact PI
PSMA-based Cancer Imaging Agents$330,091
R01 · FY2012 · CA · contact PI
Validation$207,561
U54 · FY2012 · CA · contact PI
Theranostic Imaging of Metastatic Prostate Cancer$184,483
P50 · FY2012 · CA · contact PI
Center of Cancer Nanotechnology Excellence at Johns Hopkins$2,594,165
U54 · FY2011 · CA
BETR Therapy for Herpesvirus-Associated Tumors$553,505
R01 · FY2011 · CA · contact PI
TK-based Infection Imaging$481,752
R01 · FY2011 · EB · contact PI
Small Animal Imaging Resource (SAIR)$434,709
U24 · FY2011 · CA · contact PI
GCPII-Based Brain Imaging Agents$391,757
R33 · FY2011 · MH · contact PI
PSMA-based Cancer Imaging Agents$330,091
R01 · FY2011 · CA · contact PI
Developmental Activities$242,019
U54 · FY2011 · CA · contact PI
Extrathalamic nAChR-PET for Imaging Neurodegeneration$235,178
R21 · FY2011 · AG
Validation$146,468
U54 · FY2011 · CA · contact PI
TK-based Infection Imaging$57,400
R01 · FY2011 · EB · contact PI
Center of Cancer Nanotechnology Excellence at Johns Hopkins$2,740,513
U54 · FY2010 · CA
TK-based Infection Imaging$601,187
R01 · FY2010 · EB · contact PI
BETR Therapy for Herpesvirus-Associated Tumors$582,447
R01 · FY2010 · CA · contact PI
Small Animal Imaging Resource (SAIR)$461,623
U24 · FY2010 · CA · contact PI
GCPII-Based Brain Imaging Agents$410,689
R33 · FY2010 · MH · contact PI
PSMA-based Cancer Imaging Agents$340,300
R01 · FY2010 · CA · contact PI
Developmental Activities$249,400
U54 · FY2010 · CA · contact PI
Alpha Methyl AcylCoa Racemase (AMACR)$180,400
R21 · FY2010 · CA · contact PI
Validation$141,483
U54 · FY2010 · CA · contact PI
Small Animal Imaging Resource (SAIR)$466,144
U24 · FY2009 · CA · contact PI
PSMA-based Cancer Imaging Agents$319,733
R01 · FY2009 · CA · contact PI
GCPII-Based Brain Imaging Agents$224,608
R33 · FY2009 · MH · contact PI
Alpha Methyl AcylCoa Racemase (AMACR)$216,480
R21 · FY2009 · CA · contact PI
Small Animal Imaging Resource (SAIR)$466,142
U24 · FY2008 · CA · contact PI
PSMA-based Gene Reporter-Probe System(RMI)$357,670
R21 · FY2008 · EB · contact PI
GCPII-Based Brain Imaging Agents$214,848
R21 · FY2008 · MH · contact PI
Small Animal Imaging Resource (SAIR)$471,500
U24 · FY2007 · CA · contact PI
PSMA-based Gene Reporter-Probe System(RMI)$354,495
R21 · FY2007 · EB · contact PI
GCPII-Based Brain Imaging Agents$197,300
R21 · FY2007 · MH · contact PI
PSMA-based SPECT Tracers for Prostate Cancer Imaging$151,204
R21 · FY2007 · CA · contact PI
PSMA-based PET Ligands for Prostate Cancer Imaging$151,167
R21 · FY2007 · CA · contact PI
Interdisciplinary Small Animal Imaging for Oncology$824,994
R24 · FY2006 · CA · contact PI
PSMA-based Gene Reporter-Probe System$354,966
R21 · FY2006 · EB · contact PI
Imaging Serotonergic Transmission in HIV Depression$189,545
R21 · FY2006 · MH · contact PI
PSMA-based SPECT Tracers for Prostate Cancer Imaging$186,295
R21 · FY2006 · CA · contact PI
PSMA-based PET Ligands for Prostate Cancer Imaging$186,248
R21 · FY2006 · CA · contact PI
CNS METABOLIC CORRELATES OF HIV DEMENTIA BY MRS IMAGING$36,323
P41 · FY2006 · RR · contact PI
Interdisciplinary Small Animal Imaging for Oncology$820,241
R24 · FY2005 · CA
PSMA-based Gene Reporter-Probe System(RMI)$353,436
R21 · FY2005 · EB
Imaging Serotonergic Transmission in HIV Depression$232,453
R21 · FY2005 · MH
CNS METABOLIC CORRELATES OF HIV DEMENTIA BY MRS IMAGING$43,286
P41 · FY2005 · RR
Interdisciplinary Small Animal Imaging for Oncology$797,442
R24 · FY2004 · CA
CNS METABOLIC CORRELATES OF HIV DEMENTIA BY MRS IMAGING$56,708
P41 · FY2004 · RR
Interdisciplinary Small Animal Imaging for Oncology$783,537
R24 · FY2003 · CA
Interdisciplinary Small Animal Imaging for Oncology$856,091
R24 · FY2002 · CA
Interdisciplinary Small Animal Imaging for Oncology$972,417
R24 · FY2001 · CA
CNS METABOLIC CORRELATES OF HIV DEMENTIA BY MRS IMAGING$384,677
R01 · FY2001 · MH
High Resolution Imaging in Small Animals$8,000
R13 · FY2001 · CA
CNS METABOLIC CORRELATES OF HIV DEMENTIA BY MRS IMAGING$431,974
R01 · FY2000 · MH